Instil Bio, Inc.

TIL · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 17 employees
94
SEC Filings
$8.11
Close 2026-06-01
17
Employees

Business Summary

Part I . Overview We are a biotechnology company focused on identifying and advancing innovative therapeutic opportunities. In January 2026 we announced our wholly owned subsidiary, Axion Bio, Inc., or Axion Bio, was discontinuing development of our former lead product candidate, AXN-2510, a bispecific antibody targeting both programmed death-ligand 1 and the family of vascular endothelial growth factors in solid tumor cancers. Axion Bio in-licensed AXN-2510 from ImmuneOnco Biopharmaceuticals (S...

Latest Stock Quote

TIL 2026-06-01 $8.11 O:$8.14 H:$8.2 L:$8.0299 Vol:0.0M VWAP:$8.1054
origin leaf: ad0831eb21756ab927278159fbfeaed8f4eaf8276df760d7ccc9fe10b6137e0b

Next Earnings

Q2 FY2026 — expected 2026-08-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001789769-26-000019EDGAR69K words
2025-03-042024-12-310001789769-25-000017EDGAR—
2024-03-212023-12-310001789769-24-000036EDGAR—
2023-03-312022-12-310001789769-23-000035EDGAR—
2022-03-072021-12-310001789769-22-000008EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001789769-25-000094EDGAR59K words
2025-08-132025-06-300001789769-25-000081EDGAR—
2025-05-132025-03-310001789769-25-000051EDGAR—
2024-11-132024-09-300001789769-24-000103EDGAR—
2024-08-132024-06-300001789769-24-000086EDGAR—
2024-05-102024-03-310001789769-24-000059EDGAR—
2023-11-132023-09-300001789769-23-000091EDGAR—
2023-08-142023-06-300001789769-23-000085EDGAR—
2023-05-112023-03-310001789769-23-000069EDGAR—
2022-11-142022-09-300001789769-22-000098EDGAR—
2022-08-122022-06-300001789769-22-000069EDGAR—
2022-05-162022-03-310001789769-22-000032EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001789769-26-000024EDGAR1K words
2026-03-270001789769-26-000018EDGAR—
2026-01-060001789769-26-000004EDGAR—
2025-11-130001789769-25-000092EDGAR—
2025-08-130001789769-25-000079EDGAR—
2025-07-310001789769-25-000074EDGAR—
2025-05-280001789769-25-000062EDGAR—
2025-05-270001789769-25-000059EDGAR—
2025-05-220001789769-25-000054EDGAR—
2025-05-130001789769-25-000050EDGAR—

94 total filings indexed. 67 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001789769
TickerTIL
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNY
Websitehttps://www.instilbio.com
Listed2021-03-19

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9bbcdf8abb45335baebd2cdd41300d5348da781fb7886f5831e1c4e4492c23f7
parent: ae328cf614352a14557dc98353af93da3a816c40136ad314dc35807b738638e0
content hash: 9b9d0f2aed7abef075cdb544694e639c54b005cec7fc4ef259440ebb01b3b4f9
signed: 2026-06-02T19:02:50.744Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf